BIO-key International
BKYI
3 hedge funds and large institutions have $85K invested in BIO-key International in 2020 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 0 reducing their positions, and 3 closing their positions.
25% more capital invested
Capital invested by funds: $68K → $85K (+$17K)
0% less ownership
Funds ownership: 0% → 0% (-0%)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
40% less funds holding
Funds holding: 5 → 3 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
+$9.63K |
| 2 |
TL
TrueWealth LLC
Atlanta,
Georgia
|
+$963 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$13K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$8K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$1K |
BKYI Hedge Fund Activity: Q1 2020 in Review
3 institutional investors reported a position in BIO-key International (BKYI) for Q1 2020, worth a combined $85K — up 25% from $68K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of BKYI and 2 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest buyer was HRT Financial, opening a new position worth an estimated $9.63K. The largest seller was Perkins Capital Management, exiting entirely with an estimated $13K sold.
- 3 institutional investors held BIO-key International (BKYI) as of Q1 2020, down from 5 in Q4 2019.
- Funds reported $85K of BIO-key International stock for Q1 2020, up 25% quarter-over-quarter.
- 2 funds opened new BIO-key International positions in Q1 2020 and 3 closed out, a net change of -1 holder.
- The largest BIO-key International buyer in Q1 2020 was HRT Financial, an estimated $9.63K added.
- The largest BIO-key International seller in Q1 2020 was Perkins Capital Management, an estimated $13K sold.
Based on aggregated 13F filings for Q1 2020.